Targeting the Nogo Receptor Complex in Diseases of the Central Nervous System
Keywords: Alzheimer's disease; B lymphocyte stimulator; Interferon-s; LINGO-1; Multiple Sclerosi; Parkinson's disease; Purkinje cells; Schwann cell grafts; alka-line phosphatase (AP); amyloid peptide; blood-brain barrier; central nervous system intrinsic; chondroitin sulphate proteoglycans; corticospinal tract; erythropoietin; glatiramir acetate; glucocorticosteroids; glycoprotein; glycosylphosphatidylinositol; guanosine triphosphatase; hippocampal neurons; hybridization; immunohistochemis-try; intravenous steroids; minocyclin; multiple sclerosis; mutagenesis; myelin associated inhibitory factors; myelination; neurotrophin receptor; nogo receptor; olfactory nervous system; oli-godendrocyte; oligodendrocyte mye-lin glycoprotein; oligodendrocyte precursor; proteolipid protein; remyelination; sclerosis; serotonergic axon; spinal cord injury; thoracic spinal cord
Document Type: Research Article
Publication date: 2011-01-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.